Table 2. Number of differentially expressed genes and their pathway and GO term enrichment for PMNHITTIN and PMNHIT in response to Mtb.
Contrast | DEGsa | # Genes FDRb ≤ 0.05 | # combined terms | KEGG | Reactome | GO BPc |
---|---|---|---|---|---|---|
FDR≤ 0.1 | FDR ≤ 0.1 | FDR ≤ 0.1 | ||||
PMNHIT d 6 hours(h) infected vs uninfected | Total | 7610 | 701 | 65 | 15 | 621 |
Upregulated | 3816 | 915 | 53 | 51 | 811 | |
Downregulated | 3794 | 10 | 0 | 10 | 0 | |
PMNHITTIN e 6h infected vs uninfected | Total | 6654 | 498 | 51 | 16 | 431 |
Upregulated | 3106 | 769 | 54 | 30 | 685 | |
Downregulated | 3548 | 7 | 0 | 6 | 1 | |
PMNHITTIN—PMNHIT 6h infectedf | Totalg | 2285 | 496 | 111 | 86 | 299 |
Less Upregulatedh | 1217 | 719 | 48 | 55 | 616 | |
Less Downregulatedi | 1068 | 29 | 13 | 12 | 4 |
a DEGs (Differentially expressed genes)
b FDR (false discovery rate)
c GO BP (Gene Ontology Biological Processes)
d PMNHIT (HIV-1-infected IGRA positive tuberculin positive)
e PMNHITTIN (neutrophils from HIV-1-infected persistently TB, tuberculin and IGRA negative)
f Refers to the interaction test looking at the difference in response to Mtb infection after 6h between PMNHITTIN and PMNHIT
g Refers to combined responses with significant positive and negative log2 fold change (log2FC) from the interaction test
h, i Refers to the negativeh and positivei log2FC results from the interaction test